20/20 Biolabs (AIDX) vs UL Solutions (ULS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
UL Solutions is the larger company by market cap ($13.55 billion vs $4.4 million), about 3089.7 times the size. UL Solutions pays a dividend yielding 0.82%, while 20/20 Biolabs does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AIDX | ULS |
|---|---|---|
| Share price | $0.3435 | $67.13 |
| Market cap | $4.39M | $13.55B |
| 1-day change | -2.55% | -1.81% |
| YTD return | — | -14.87% |
| 1-year return | — | -8.62% |
| P/E ratio (TTM) | — | 27.07 |
| Forward P/E | — | 25.81 |
| EPS (TTM) | $-0.73 | $2.48 |
| Dividend yield | 0.00% | 0.82% |
| Annual dividend | $0.00 | $0.55 |
| Revenue (latest FY) | — | $3.05B |
| Revenue growth (YoY) | — | +6.38% |
| Net income (latest FY) | — | $325.00M |
| Gross margin | — | 49.46% |
| Operating margin | — | 17.10% |
| Net margin | — | 10.65% |
| 52-week high | $50.00 | $107.54 |
| 52-week low | $0.33 | $63.17 |
| Distance from 52-week high | -99.31% | -37.58% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +43.72% |
| Average volume | 91.83K | 890.60K |
| Shares outstanding | 12.77M | 78.14M |
| Employees | — | 14,587 |
| Sector | Health Care | Health Care |
| Industry | Precision Instruments | Precision Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UL Solutions is about 3089.7 times larger than 20/20 Biolabs by market value ($13.55B vs $4.39M).
About UL Solutions
ULS stock →UL Solutions Inc., together with its subsidiaries, provides testing, inspection and certification services and related software and advisory services worldwide. It operates through three segments: Industrial, Consumer, and Software and Advisory.
Health Care · Precision Instruments · 14,587 employees
AIDX vs ULS FAQ
Which is bigger, 20/20 Biolabs or UL Solutions?
UL Solutions (ULS) is larger, with a market capitalization of $13.55B compared with $4.39M for 20/20 Biolabs (AIDX).
Which pays a higher dividend, 20/20 Biolabs or UL Solutions?
UL Solutions pays a dividend yielding 0.82%, while 20/20 Biolabs does not currently pay a regular dividend.
Are 20/20 Biolabs and UL Solutions in the same industry?
Yes. Both are classified in the Precision Instruments industry within the Health Care sector.